文献速递肿瘤 PET/CT

定义弥漫大B细胞淋巴瘤基线代谢肿瘤体积的最佳测量方法

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-02-19

本研究在147例于Guy's and St Thomas'医院治疗的弥漫大B细胞淋巴瘤患者中,比较了三种FDG PET代谢肿瘤体积测量方法(SUV≥2.5、SUV≥最大SUV的41%、SUV≥肝脏平均摄取(PERCIST))及两种软件程序。所有方法预测无进展生存和总生存的准确性相似,但区分预后好坏的阈值因方法而异。SUV≥2.5方法观察者间一致性最佳且最易应用。

要点

  • 所有MTV测量方法预测PFS和OS的准确性相似。
  • 不同方法得出的预后区分阈值差异显著。
  • SUV≥2.5方法观察者间一致性最佳且最易应用。

核心结论

  • 所有方法预测PFS和OS的准确性相似,但区分预后好坏的阈值因方法而异。
  • 选择最佳方法应主要依据预后价值,临床使用还需考虑易用性和可重复性。
  • 本研究中所有方法均能预测预后,但SUV≥2.5具有最佳的观察者间一致性且最易应用。

研究设计与样本

  • 在Guy's and St Thomas'医院治疗的147例连续未选择的弥漫大B细胞淋巴瘤患者中,于治疗前FDG PET测量MTV。
  • 比较三种MTV测量方法:SUV≥2.5、SUV≥最大SUV的41%、SUV≥肝脏平均摄取(PERCIST)。
  • 比较两种软件程序测量SUV≥2.5:自研PETTRA软件和Hermes商业软件。

主要发现

  • 四种方法测得的MTV之间强相关,但41%方法得出的阈值非常不同。
  • 预测PFS的最佳截断值范围为166-400cm3。
  • 低MTV组与高MTV组的5年PFS分别为83-87%与42-44%,5年OS分别为85-89%与55-58%。
  • 50例患者观察者间变异显示一致性极好,但SUV≥2.5方法变异最低。
  • 41%方法最复杂且耗时最长。

关键数值与推荐

  • 预测PFS的最佳截断值范围为166-400cm3,具体取决于所用方法。
  • 低MTV组5年PFS为83-87%,高MTV组为42-44%。
  • 低MTV组5年OS为85-89%,高MTV组为55-58%。

临床怎么用

  • 作者认为选择最佳方法应主要依据预后价值,临床使用还需考虑易用性和可重复性。
  • 本研究中SUV≥2.5具有最佳的观察者间一致性且最易应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Metabolic tumour volume (MTV) is a promising prognostic indicator in diffuse large B cell lymphoma (DLBCL). Optimal thresholds to divide patients into 'low' versus 'high' MTV groups depend on clinical characteristics and the measurement method. The aim of this study was to compare in consecutive unselected patients with DLBCL, different software algorithms and published methods of MTV measurement using FDG PET. METHOD: Pretreatment MTV was measured on 147 patients treated at Guy's and St Thomas' Hospital. We compared 3 methods: SUV ≥2.5, SUV ≥41% of maximum SUV and SUV ≥ mean liver uptake (PERCIST) and compared 2 software programs for measuring SUV ≥2.5; in-house 'PETTRA' software and Hermes commercial software. RESULTS: There was strong correlation between MTV using the 4 methods, although derived thresholds were very different for the 41% method. Optimal cut-offs for predicting PFS ranged from 166-400cm3. All methods predicted survival with similar accuracy. 5y-PFS was 83-87% vs. 42-44% and 5y-OS was 85-89% vs. 55-58% for the low- and high-MTV groups, respectively. Interobserver variation in 50 patients showed excellent agreement, though variation was lowest using the SUV ≥ 2.5 method. The 41% method was the most complex and took the longest time. CONCLUSION: All methods predicted PFS and OS with similar accuracy, but the derived cut-off separating good from poor prognosis varied markedly depending on the method. The choice of the optimal method should rely primarily on prognostic value, but for clinical use needs to take account of ease of use and reproducibility. In this study, all methods predicted prognosis, but SUV ≥ 2.5 had the best inter-observer agreement and was easiest to apply.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ilyas H, Mikhaeel NG, Dunn JT, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. PMID: 29460024. doi:10.1007/s00259-018-3953-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。